$Global Crude Unfractionated Heparin (UFH) Supply, Demand and Key Producers, 2023-2029$

Global Crude Unfractionated Heparin (UFH) Supply, Demand and Key Producers, 2023-2029

Page: 113

Published Date: 05 Sep 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Crude Unfractionated Heparin (UFH) market size is expected to reach $ 9220.1 million by 2029, rising at a market growth of 10.4% CAGR during the forecast period (2023-2029).

Currently, there are many players in this market. Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals and some others are playing important roles in Crude Heparin industry. The market is dispersed for now and is seeing to be more concentrated in the future. Companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The total competition market for Crude Heparin will become more intense, while the market is going to be more concentrated in the future. Overall, the Crude Heparin products performance is positive with the current environment status.

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

This report studies the global Crude Unfractionated Heparin (UFH) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Crude Unfractionated Heparin (UFH), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Crude Unfractionated Heparin (UFH) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Crude Unfractionated Heparin (UFH) total production and demand, 2018-2029, (MT)
Global Crude Unfractionated Heparin (UFH) total production value, 2018-2029, (USD Million)
Global Crude Unfractionated Heparin (UFH) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (MT)
Global Crude Unfractionated Heparin (UFH) consumption by region & country, CAGR, 2018-2029 & (MT)
U.S. VS China: Crude Unfractionated Heparin (UFH) domestic production, consumption, key domestic manufacturers and share
Global Crude Unfractionated Heparin (UFH) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (MT)
Global Crude Unfractionated Heparin (UFH) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (MT)
Global Crude Unfractionated Heparin (UFH) production by Application production, value, CAGR, 2018-2029, (USD Million) & (MT).

This reports profiles key players in the global Crude Unfractionated Heparin (UFH) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Crude Unfractionated Heparin (UFH) market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Crude Unfractionated Heparin (UFH) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Crude Unfractionated Heparin (UFH) Market, Segmentation by Type
    Pig Intestine Mucosa Heparin
    Bovine Heparin and Others

Global Crude Unfractionated Heparin (UFH) Market, Segmentation by Application
    Unfractionated Heparin (UFH)
    Low-Molecular-Weight Heparin (LMWH)

Companies Profiled:
    Bioiberica
    Shenzhen Hepalink
    Sanofi
    Nanjing King-friend
    Fengrun Biological Technology
    Aspen Oss
    Hebei Changshan Biochemical
    Changzhou Qianhong
    Hepac (Darling Ingredients)
    Huaian MDC Pharmaceutical
    Yantai Dongcheng Biochemicals

Key Questions Answered
1. How big is the global Crude Unfractionated Heparin (UFH) market?
2. What is the demand of the global Crude Unfractionated Heparin (UFH) market?
3. What is the year over year growth of the global Crude Unfractionated Heparin (UFH) market?
4. What is the production and production value of the global Crude Unfractionated Heparin (UFH) market?
5. Who are the key producers in the global Crude Unfractionated Heparin (UFH) market?

Table of Contents

1 Supply Summary
    1.1 Crude Unfractionated Heparin (UFH) Introduction
    1.2 World Crude Unfractionated Heparin (UFH) Supply & Forecast
        1.2.1 World Crude Unfractionated Heparin (UFH) Production Value (2018 & 2022 & 2029)
        1.2.2 World Crude Unfractionated Heparin (UFH) Production (2018-2029)
        1.2.3 World Crude Unfractionated Heparin (UFH) Pricing Trends (2018-2029)
    1.3 World Crude Unfractionated Heparin (UFH) Production by Region (Based on Production Site)
        1.3.1 World Crude Unfractionated Heparin (UFH) Production Value by Region (2018-2029)
        1.3.2 World Crude Unfractionated Heparin (UFH) Production by Region (2018-2029)
        1.3.3 World Crude Unfractionated Heparin (UFH) Average Price by Region (2018-2029)
        1.3.4 North America Crude Unfractionated Heparin (UFH) Production (2018-2029)
        1.3.5 Europe Crude Unfractionated Heparin (UFH) Production (2018-2029)
        1.3.6 China Crude Unfractionated Heparin (UFH) Production (2018-2029)
        1.3.7 Japan Crude Unfractionated Heparin (UFH) Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Crude Unfractionated Heparin (UFH) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Crude Unfractionated Heparin (UFH) Major Market Trends

2 Demand Summary
    2.1 World Crude Unfractionated Heparin (UFH) Demand (2018-2029)
    2.2 World Crude Unfractionated Heparin (UFH) Consumption by Region
        2.2.1 World Crude Unfractionated Heparin (UFH) Consumption by Region (2018-2023)
        2.2.2 World Crude Unfractionated Heparin (UFH) Consumption Forecast by Region (2024-2029)
    2.3 United States Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.4 China Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.5 Europe Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.6 Japan Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.7 South Korea Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.8 ASEAN Crude Unfractionated Heparin (UFH) Consumption (2018-2029)
    2.9 India Crude Unfractionated Heparin (UFH) Consumption (2018-2029)

3 World Crude Unfractionated Heparin (UFH) Manufacturers Competitive Analysis
    3.1 World Crude Unfractionated Heparin (UFH) Production Value by Manufacturer (2018-2023)
    3.2 World Crude Unfractionated Heparin (UFH) Production by Manufacturer (2018-2023)
    3.3 World Crude Unfractionated Heparin (UFH) Average Price by Manufacturer (2018-2023)
    3.4 Crude Unfractionated Heparin (UFH) Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Crude Unfractionated Heparin (UFH) Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Crude Unfractionated Heparin (UFH) in 2022
        3.5.3 Global Concentration Ratios (CR8) for Crude Unfractionated Heparin (UFH) in 2022
    3.6 Crude Unfractionated Heparin (UFH) Market: Overall Company Footprint Analysis
        3.6.1 Crude Unfractionated Heparin (UFH) Market: Region Footprint
        3.6.2 Crude Unfractionated Heparin (UFH) Market: Company Product Type Footprint
        3.6.3 Crude Unfractionated Heparin (UFH) Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Crude Unfractionated Heparin (UFH) Production Value Comparison
        4.1.1 United States VS China: Crude Unfractionated Heparin (UFH) Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Crude Unfractionated Heparin (UFH) Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Crude Unfractionated Heparin (UFH) Production Comparison
        4.2.1 United States VS China: Crude Unfractionated Heparin (UFH) Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Crude Unfractionated Heparin (UFH) Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Crude Unfractionated Heparin (UFH) Consumption Comparison
        4.3.1 United States VS China: Crude Unfractionated Heparin (UFH) Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Crude Unfractionated Heparin (UFH) Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Crude Unfractionated Heparin (UFH) Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023)
    4.5 China Based Crude Unfractionated Heparin (UFH) Manufacturers and Market Share
        4.5.1 China Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value (2018-2023)
        4.5.3 China Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023)
    4.6 Rest of World Based Crude Unfractionated Heparin (UFH) Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023)

5 Market Analysis by Type
    5.1 World Crude Unfractionated Heparin (UFH) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Pig Intestine Mucosa Heparin
        5.2.2 Bovine Heparin and Others
    5.3 Market Segment by Type
        5.3.1 World Crude Unfractionated Heparin (UFH) Production by Type (2018-2029)
        5.3.2 World Crude Unfractionated Heparin (UFH) Production Value by Type (2018-2029)
        5.3.3 World Crude Unfractionated Heparin (UFH) Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Crude Unfractionated Heparin (UFH) Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Unfractionated Heparin (UFH)
        6.2.2 Low-Molecular-Weight Heparin (LMWH)
    6.3 Market Segment by Application
        6.3.1 World Crude Unfractionated Heparin (UFH) Production by Application (2018-2029)
        6.3.2 World Crude Unfractionated Heparin (UFH) Production Value by Application (2018-2029)
        6.3.3 World Crude Unfractionated Heparin (UFH) Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bioiberica
        7.1.1 Bioiberica Details
        7.1.2 Bioiberica Major Business
        7.1.3 Bioiberica Crude Unfractionated Heparin (UFH) Product and Services
        7.1.4 Bioiberica Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bioiberica Recent Developments/Updates
        7.1.6 Bioiberica Competitive Strengths & Weaknesses
    7.2 Shenzhen Hepalink
        7.2.1 Shenzhen Hepalink Details
        7.2.2 Shenzhen Hepalink Major Business
        7.2.3 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product and Services
        7.2.4 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Shenzhen Hepalink Recent Developments/Updates
        7.2.6 Shenzhen Hepalink Competitive Strengths & Weaknesses
    7.3 Sanofi
        7.3.1 Sanofi Details
        7.3.2 Sanofi Major Business
        7.3.3 Sanofi Crude Unfractionated Heparin (UFH) Product and Services
        7.3.4 Sanofi Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Sanofi Recent Developments/Updates
        7.3.6 Sanofi Competitive Strengths & Weaknesses
    7.4 Nanjing King-friend
        7.4.1 Nanjing King-friend Details
        7.4.2 Nanjing King-friend Major Business
        7.4.3 Nanjing King-friend Crude Unfractionated Heparin (UFH) Product and Services
        7.4.4 Nanjing King-friend Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Nanjing King-friend Recent Developments/Updates
        7.4.6 Nanjing King-friend Competitive Strengths & Weaknesses
    7.5 Fengrun Biological Technology
        7.5.1 Fengrun Biological Technology Details
        7.5.2 Fengrun Biological Technology Major Business
        7.5.3 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product and Services
        7.5.4 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Fengrun Biological Technology Recent Developments/Updates
        7.5.6 Fengrun Biological Technology Competitive Strengths & Weaknesses
    7.6 Aspen Oss
        7.6.1 Aspen Oss Details
        7.6.2 Aspen Oss Major Business
        7.6.3 Aspen Oss Crude Unfractionated Heparin (UFH) Product and Services
        7.6.4 Aspen Oss Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Aspen Oss Recent Developments/Updates
        7.6.6 Aspen Oss Competitive Strengths & Weaknesses
    7.7 Hebei Changshan Biochemical
        7.7.1 Hebei Changshan Biochemical Details
        7.7.2 Hebei Changshan Biochemical Major Business
        7.7.3 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product and Services
        7.7.4 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Hebei Changshan Biochemical Recent Developments/Updates
        7.7.6 Hebei Changshan Biochemical Competitive Strengths & Weaknesses
    7.8 Changzhou Qianhong
        7.8.1 Changzhou Qianhong Details
        7.8.2 Changzhou Qianhong Major Business
        7.8.3 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product and Services
        7.8.4 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Changzhou Qianhong Recent Developments/Updates
        7.8.6 Changzhou Qianhong Competitive Strengths & Weaknesses
    7.9 Hepac (Darling Ingredients)
        7.9.1 Hepac (Darling Ingredients) Details
        7.9.2 Hepac (Darling Ingredients) Major Business
        7.9.3 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product and Services
        7.9.4 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
        7.9.6 Hepac (Darling Ingredients) Competitive Strengths & Weaknesses
    7.10 Huaian MDC Pharmaceutical
        7.10.1 Huaian MDC Pharmaceutical Details
        7.10.2 Huaian MDC Pharmaceutical Major Business
        7.10.3 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product and Services
        7.10.4 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
        7.10.6 Huaian MDC Pharmaceutical Competitive Strengths & Weaknesses
    7.11 Yantai Dongcheng Biochemicals
        7.11.1 Yantai Dongcheng Biochemicals Details
        7.11.2 Yantai Dongcheng Biochemicals Major Business
        7.11.3 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product and Services
        7.11.4 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates
        7.11.6 Yantai Dongcheng Biochemicals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Crude Unfractionated Heparin (UFH) Industry Chain
    8.2 Crude Unfractionated Heparin (UFH) Upstream Analysis
        8.2.1 Crude Unfractionated Heparin (UFH) Core Raw Materials
        8.2.2 Main Manufacturers of Crude Unfractionated Heparin (UFH) Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Crude Unfractionated Heparin (UFH) Production Mode
    8.6 Crude Unfractionated Heparin (UFH) Procurement Model
    8.7 Crude Unfractionated Heparin (UFH) Industry Sales Model and Sales Channels
        8.7.1 Crude Unfractionated Heparin (UFH) Sales Model
        8.7.2 Crude Unfractionated Heparin (UFH) Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Crude Unfractionated Heparin (UFH) Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Crude Unfractionated Heparin (UFH) Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Crude Unfractionated Heparin (UFH) Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Region (2018-2023)
    Table 5. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Region (2024-2029)
    Table 6. World Crude Unfractionated Heparin (UFH) Production by Region (2018-2023) & (MT)
    Table 7. World Crude Unfractionated Heparin (UFH) Production by Region (2024-2029) & (MT)
    Table 8. World Crude Unfractionated Heparin (UFH) Production Market Share by Region (2018-2023)
    Table 9. World Crude Unfractionated Heparin (UFH) Production Market Share by Region (2024-2029)
    Table 10. World Crude Unfractionated Heparin (UFH) Average Price by Region (2018-2023) & (US$/Kg)
    Table 11. World Crude Unfractionated Heparin (UFH) Average Price by Region (2024-2029) & (US$/Kg)
    Table 12. Crude Unfractionated Heparin (UFH) Major Market Trends
    Table 13. World Crude Unfractionated Heparin (UFH) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (MT)
    Table 14. World Crude Unfractionated Heparin (UFH) Consumption by Region (2018-2023) & (MT)
    Table 15. World Crude Unfractionated Heparin (UFH) Consumption Forecast by Region (2024-2029) & (MT)
    Table 16. World Crude Unfractionated Heparin (UFH) Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Crude Unfractionated Heparin (UFH) Producers in 2022
    Table 18. World Crude Unfractionated Heparin (UFH) Production by Manufacturer (2018-2023) & (MT)
    Table 19. Production Market Share of Key Crude Unfractionated Heparin (UFH) Producers in 2022
    Table 20. World Crude Unfractionated Heparin (UFH) Average Price by Manufacturer (2018-2023) & (US$/Kg)
    Table 21. Global Crude Unfractionated Heparin (UFH) Company Evaluation Quadrant
    Table 22. World Crude Unfractionated Heparin (UFH) Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Crude Unfractionated Heparin (UFH) Production Site of Key Manufacturer
    Table 24. Crude Unfractionated Heparin (UFH) Market: Company Product Type Footprint
    Table 25. Crude Unfractionated Heparin (UFH) Market: Company Product Application Footprint
    Table 26. Crude Unfractionated Heparin (UFH) Competitive Factors
    Table 27. Crude Unfractionated Heparin (UFH) New Entrant and Capacity Expansion Plans
    Table 28. Crude Unfractionated Heparin (UFH) Mergers & Acquisitions Activity
    Table 29. United States VS China Crude Unfractionated Heparin (UFH) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Crude Unfractionated Heparin (UFH) Production Comparison, (2018 & 2022 & 2029) & (MT)
    Table 31. United States VS China Crude Unfractionated Heparin (UFH) Consumption Comparison, (2018 & 2022 & 2029) & (MT)
    Table 32. United States Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023) & (MT)
    Table 36. United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share (2018-2023)
    Table 37. China Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023) & (MT)
    Table 41. China Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share (2018-2023)
    Table 42. Rest of World Based Crude Unfractionated Heparin (UFH) Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production (2018-2023) & (MT)
    Table 46. Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share (2018-2023)
    Table 47. World Crude Unfractionated Heparin (UFH) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Crude Unfractionated Heparin (UFH) Production by Type (2018-2023) & (MT)
    Table 49. World Crude Unfractionated Heparin (UFH) Production by Type (2024-2029) & (MT)
    Table 50. World Crude Unfractionated Heparin (UFH) Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Crude Unfractionated Heparin (UFH) Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Crude Unfractionated Heparin (UFH) Average Price by Type (2018-2023) & (US$/Kg)
    Table 53. World Crude Unfractionated Heparin (UFH) Average Price by Type (2024-2029) & (US$/Kg)
    Table 54. World Crude Unfractionated Heparin (UFH) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Crude Unfractionated Heparin (UFH) Production by Application (2018-2023) & (MT)
    Table 56. World Crude Unfractionated Heparin (UFH) Production by Application (2024-2029) & (MT)
    Table 57. World Crude Unfractionated Heparin (UFH) Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Crude Unfractionated Heparin (UFH) Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Crude Unfractionated Heparin (UFH) Average Price by Application (2018-2023) & (US$/Kg)
    Table 60. World Crude Unfractionated Heparin (UFH) Average Price by Application (2024-2029) & (US$/Kg)
    Table 61. Bioiberica Basic Information, Manufacturing Base and Competitors
    Table 62. Bioiberica Major Business
    Table 63. Bioiberica Crude Unfractionated Heparin (UFH) Product and Services
    Table 64. Bioiberica Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bioiberica Recent Developments/Updates
    Table 66. Bioiberica Competitive Strengths & Weaknesses
    Table 67. Shenzhen Hepalink Basic Information, Manufacturing Base and Competitors
    Table 68. Shenzhen Hepalink Major Business
    Table 69. Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product and Services
    Table 70. Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Shenzhen Hepalink Recent Developments/Updates
    Table 72. Shenzhen Hepalink Competitive Strengths & Weaknesses
    Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 74. Sanofi Major Business
    Table 75. Sanofi Crude Unfractionated Heparin (UFH) Product and Services
    Table 76. Sanofi Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Sanofi Recent Developments/Updates
    Table 78. Sanofi Competitive Strengths & Weaknesses
    Table 79. Nanjing King-friend Basic Information, Manufacturing Base and Competitors
    Table 80. Nanjing King-friend Major Business
    Table 81. Nanjing King-friend Crude Unfractionated Heparin (UFH) Product and Services
    Table 82. Nanjing King-friend Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Nanjing King-friend Recent Developments/Updates
    Table 84. Nanjing King-friend Competitive Strengths & Weaknesses
    Table 85. Fengrun Biological Technology Basic Information, Manufacturing Base and Competitors
    Table 86. Fengrun Biological Technology Major Business
    Table 87. Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product and Services
    Table 88. Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Fengrun Biological Technology Recent Developments/Updates
    Table 90. Fengrun Biological Technology Competitive Strengths & Weaknesses
    Table 91. Aspen Oss Basic Information, Manufacturing Base and Competitors
    Table 92. Aspen Oss Major Business
    Table 93. Aspen Oss Crude Unfractionated Heparin (UFH) Product and Services
    Table 94. Aspen Oss Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Aspen Oss Recent Developments/Updates
    Table 96. Aspen Oss Competitive Strengths & Weaknesses
    Table 97. Hebei Changshan Biochemical Basic Information, Manufacturing Base and Competitors
    Table 98. Hebei Changshan Biochemical Major Business
    Table 99. Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product and Services
    Table 100. Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Hebei Changshan Biochemical Recent Developments/Updates
    Table 102. Hebei Changshan Biochemical Competitive Strengths & Weaknesses
    Table 103. Changzhou Qianhong Basic Information, Manufacturing Base and Competitors
    Table 104. Changzhou Qianhong Major Business
    Table 105. Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product and Services
    Table 106. Changzhou Qianhong Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Changzhou Qianhong Recent Developments/Updates
    Table 108. Changzhou Qianhong Competitive Strengths & Weaknesses
    Table 109. Hepac (Darling Ingredients) Basic Information, Manufacturing Base and Competitors
    Table 110. Hepac (Darling Ingredients) Major Business
    Table 111. Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product and Services
    Table 112. Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Hepac (Darling Ingredients) Recent Developments/Updates
    Table 114. Hepac (Darling Ingredients) Competitive Strengths & Weaknesses
    Table 115. Huaian MDC Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 116. Huaian MDC Pharmaceutical Major Business
    Table 117. Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product and Services
    Table 118. Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Huaian MDC Pharmaceutical Recent Developments/Updates
    Table 120. Yantai Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
    Table 121. Yantai Dongcheng Biochemicals Major Business
    Table 122. Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product and Services
    Table 123. Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Production (MT), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 124. Global Key Players of Crude Unfractionated Heparin (UFH) Upstream (Raw Materials)
    Table 125. Crude Unfractionated Heparin (UFH) Typical Customers
    Table 126. Crude Unfractionated Heparin (UFH) Typical Distributors
List of Figure
    Figure 1. Crude Unfractionated Heparin (UFH) Picture
    Figure 2. World Crude Unfractionated Heparin (UFH) Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Crude Unfractionated Heparin (UFH) Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Crude Unfractionated Heparin (UFH) Production (2018-2029) & (MT)
    Figure 5. World Crude Unfractionated Heparin (UFH) Average Price (2018-2029) & (US$/Kg)
    Figure 6. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Region (2018-2029)
    Figure 7. World Crude Unfractionated Heparin (UFH) Production Market Share by Region (2018-2029)
    Figure 8. North America Crude Unfractionated Heparin (UFH) Production (2018-2029) & (MT)
    Figure 9. Europe Crude Unfractionated Heparin (UFH) Production (2018-2029) & (MT)
    Figure 10. China Crude Unfractionated Heparin (UFH) Production (2018-2029) & (MT)
    Figure 11. Japan Crude Unfractionated Heparin (UFH) Production (2018-2029) & (MT)
    Figure 12. Crude Unfractionated Heparin (UFH) Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 15. World Crude Unfractionated Heparin (UFH) Consumption Market Share by Region (2018-2029)
    Figure 16. United States Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 17. China Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 18. Europe Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 19. Japan Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 20. South Korea Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 21. ASEAN Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 22. India Crude Unfractionated Heparin (UFH) Consumption (2018-2029) & (MT)
    Figure 23. Producer Shipments of Crude Unfractionated Heparin (UFH) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Crude Unfractionated Heparin (UFH) Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Crude Unfractionated Heparin (UFH) Markets in 2022
    Figure 26. United States VS China: Crude Unfractionated Heparin (UFH) Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Crude Unfractionated Heparin (UFH) Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Crude Unfractionated Heparin (UFH) Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share 2022
    Figure 30. China Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Crude Unfractionated Heparin (UFH) Production Market Share 2022
    Figure 32. World Crude Unfractionated Heparin (UFH) Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Type in 2022
    Figure 34. Pig Intestine Mucosa Heparin
    Figure 35. Bovine Heparin and Others
    Figure 36. World Crude Unfractionated Heparin (UFH) Production Market Share by Type (2018-2029)
    Figure 37. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Type (2018-2029)
    Figure 38. World Crude Unfractionated Heparin (UFH) Average Price by Type (2018-2029) & (US$/Kg)
    Figure 39. World Crude Unfractionated Heparin (UFH) Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Application in 2022
    Figure 41. Unfractionated Heparin (UFH)
    Figure 42. Low-Molecular-Weight Heparin (LMWH)
    Figure 43. World Crude Unfractionated Heparin (UFH) Production Market Share by Application (2018-2029)
    Figure 44. World Crude Unfractionated Heparin (UFH) Production Value Market Share by Application (2018-2029)
    Figure 45. World Crude Unfractionated Heparin (UFH) Average Price by Application (2018-2029) & (US$/Kg)
    Figure 46. Crude Unfractionated Heparin (UFH) Industry Chain
    Figure 47. Crude Unfractionated Heparin (UFH) Procurement Model
    Figure 48. Crude Unfractionated Heparin (UFH) Sales Model
    Figure 49. Crude Unfractionated Heparin (UFH) Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals

Related Reports

$Global Crude Unfractionated Heparin (UFH) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029$

Global Crude Unfractionated Heparin (UFH) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Sep 2023

date Chemical & Material

According to our (Global Info Research) latest study, the global Crude Unfractionated Heparin (UFH) market size was valued at USD 4603.5 million in 2022 and is forecast to a readjusted size of USD 9220.1 million by 2029 with a CAGR of 10.4% during review period.

$Global Crude Unfractionated Heparin (UFH) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030$

Global Crude Unfractionated Heparin (UFH) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Chemical & Material

According to our (Global Info Research) latest study, the global Crude Unfractionated Heparin (UFH) market size was valued at USD 4603.5 million in 2023 and is forecast to a readjusted size of USD 9220.1 million by 2030 with a CAGR of 10.4% during review period.

Product Tags

crude unfractionated heparin ufh

Crude Unfractionated Heparin (UFH)

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>